Veda N. Giri, MD
Veda N. Giri, MD, is a Professor in Medical Oncology and Cancer Biology at the Sidney Kimmel Cancer Center (SKCC) at Jefferson. She is a medical oncologist with a clinical and research interest in inherited cancer risk assessment. She is the Director of Cancer Risk Assessment and Clinical Cancer Genetics which provides patients with genetic counseling, genetic testing and cancer screening recommendations along with the opportunity to take part in innovative research and patient-centered initiatives.
Dr. Giri received her medical degree from Sidney Kimmel Medical College, and proceeded to complete her residency in Internal Medicine and fellowship in Hematology-Oncology at the University of Michigan. She then completed advanced training in molecular cancer genetics and cancer risk assessment at Fox Chase Cancer Center (FCCC). From 2006-2014, she directed prostate cancer risk assessment at FCCC, developing studies focused on evaluating the role of genetic markers in prostate cancer risk assessment. In 2014, Dr. Giri assumed her role as Director of Cancer Risk Assessment and Clinical Cancer Genetics at SKCC with the overall goal to develop a comprehensive translational program for patient evaluation and research endeavors.
Dr. Giri has served on national committees including the National Comprehensive Cancer Network Prostate Cancer Early Detection Panel and NIH PDQ® Cancer Genetics Editorial Board, contributing expertise in prostate cancer risk assessment and prostate cancer genetics at the national level. She is continuing research efforts to identify and characterize the inherited basis of prostate cancer to develop the field of genetic testing for prostate cancer. A further goal of Dr. Giri’s research is to study cancer risk in diverse populations, and address community needs regarding engagement in cancer risk assessment.
Susan Miller-Samuel, MSN, RN, AGN-BC
Susan Miller-Samuel is a board-certified Advanced Genetics Nurse (AGN-BC). She received her Bachelor’s Degree in nursing (BSN) from The Pennsylvania State University and her Master’s Degree in nursing (MSN) from LaSalle University. She completed an internship in cancer genetics at Roswell Park Cancer Institute in Buffalo NY.
Sue has provided cancer risk assessment and genetic counseling for nearly 20 years at Jefferson. While she spends most of her time providing counseling and education about hereditary cancer syndromes to higher- risk individuals and their families, Sue is also an Adjunct Instructor for the Jefferson School of Nursing at Thomas Jefferson University and a Lecturer for “The Molecular and Cellular Basis of Medicine” course at the Sidney Kimmel Medical College at Thomas Jefferson University. She serves as a Genetics Content Expert Panel Member for the American Nurses Credentialing Center (ANCC), the board-certifying organization for Advanced Genetics Nursing. Sue has authored or co-authored multiple articles and book chapters in the field of cancer genetics. Sue’s clinical focus is in genetic counseling and genetic testing for hereditary breast and ovarian cancer.
Meredith Kohn RN, MS
Meredith Kohn is the clinical nurse specialist and coordinator for the Cancer Genetics Risk Assessment Program at the Rosenfeld Cancer Center at Abington – Jefferson Health. Meredith has been responsible for the development and ongoing growth of the Risk Assessment Program since its inception 15 years ago. She received her Master of Science Degree from the School of Nursing and a Certificate in Administration from the School of Business at the University of Maryland. She has received extensive educational preparation for her role through the National Institute of Health/Fox Chase Cancer Center Advanced Cancer Risk Counseling Training for Nurses and the University of Pennsylvania. She also has an extensive background in oncology nursing. Meredith provides genetic counseling primarily to patients and families at risk for hereditary breast, gynecologic and gastrointestinal malignancies.
Laura Gross, BA
Laura Gross became program manager for the Clinical Cancer Genetics Program in 2014. After receiving a biology degree from Rutgers University, she began her career in cancer research as a research assistant in a tumor immunology laboratory concentrating on melanoma. After working in the lab for 10 years, Laura wanted to have more patient interaction, and took on the role of project manager for a research study providing prostate cancer screening for men at high-risk for prostate cancer. During this time, she developed an interest in the genetic evaluation for inherited cancer risk for all types of cancers. As program manager for the Clinical Cancer Genetics Program, Laura works closely with the genetics providers and coordinates all of Dr. Giri’s research studies, focusing on cancer risk, genetic counseling, genetic testing, screening and prevention. She also coordinates summer internships for high school and college students to engage in cancer research at the Sidney Kimmel Cancer Center at Jefferson.
Nicole Crumpler, MS, MBA
Nicole Crumpler is currently the laboratory manager for the Clinical Cancer Genetics Program. Prior to joining the team at the Sidney Kimmel Cancer Center at Jefferson in 2014, Nicole received her Master’s Degree in Biotechnology and a Master’s Degree in Business Administration from Johns Hopkins University in 2007. Nicole’s primary roles within the Clinical Genetics Program are managing and processing patient samples for all of Dr. Giri’s research studies along with assay development, data analysis and training students in cancer risk research.
Karen Robison, CMA
Karen Robison joined The Cancer Risk Assessment and Clinical Cancer Genetics Program in January of 2016, and serves as the Patient Intake Coordinator. Karen is a Certified Medical Assistant with experience in oncology care. She has been with Thomas Jefferson University Hospital for 20 years. Karen’s primary role is communicating with patients to obtain intake information, retrieving medical records and scheduling patient visits with the cancer genetics team.
Lora Rhodes, MSW, LSW
Lora received her BS in psychology from The Pennsylvania State University and MSW from Rutgers University. A social worker for over 25 years, she returned to clinical work in 2014 at the Sidney Kimmel Cancer Center at Jefferson, where she began her career in oncology social work in 1996. Prior to her current position, she worked in continuing medical education, developing education programs for physicians, nurses and social workers. In her work with the Clinical Cancer Genetics Program, Lora helps individuals and families with the psychological, social, emotional, and financial issues that can accompany being at high genetic or hereditary risk for cancer. Lora also helps individuals with practical needs, such as finding community resources and understanding insurance coverage.
Kylie Borden, MS, LCGC
Kylie Borden joined our Clinical Cancer genetics program in 2021 and specializes in inherited cancer syndromes. Prior to coming to the Sidney Kimmel Cancer Center – Jefferson Health, Kylie worked in genetics research at the National Cancer Institute - National Institutes of Health. Kylie is board certified by the American Board of Genetic Counseling, she received her B.S. in Biochemistry from Southwestern University in Texas, and her M.S. in Genetic Counseling from the University of Pennsylvania.
Amanda Back, MS, LCGC
Amanda Back is a certified genetic counselor who joined the Sidney Kimmel Cancer Center in 2020. Amanda was trained at Arcadia University’s Genetic Counseling Training Program and, as an undergraduate, she studied at the College of William & Mary where she double majored in Neuroscience and Religious Studies. Amanda’s clinical focus is in genetic counseling for hereditary breast cancer and gynecological cancers—with an interest in reproductive oncology.
Outside of direct patient care Amanda is actively involved with both the National Society of Genetic Counselors (NSGC) and Pennsylvania Association of Genetic Counselors (PAGC). Beginning in 2020, Amanda Chaired a working-group through PAGC to establish an action plan in areas related to justice, equity, diversity, and inclusion (JEDI) in the field of genetic counseling in Pennsylvania. Presently, she is the Chair of PAGC’s Education Committee. Recently, Amanda was selected to sit on NSGC’s Task Force for JEDI. Her research interests include diversifying best-practices in patient care, patient decision-making, and social determinants of healthcare access.
Ashley Peck, BS
Ashley Peck received her BS- Health Science degree from Thomas Jefferson University. She has joined the Sidney Kimmel Cancer Center- Jefferson Health Cancer Risk Assessment and Clinical Cancer Genetics Program in 2022, with responsibility of Patient Intake Coordinator. Ashley has experience in oncology care with recent work in our SKCC Medical Oncology Department and views her new role as additional learning opportunities for how to help patients through their oncology care at our Sidney Kimmel Cancer Center. Ashley’s new role focuses on coordinating new patient consultations by obtaining cancer genetic intake/triage information for their visit and providing patients information of what to expect at their new patient appointment with a Cancer Genetics provider. Ashley is passionate about patient care and enjoys speaking with new patients daily.
Rebecca Jaslow, MD
Rebecca Jaslow, MD, is an Asst. Professor in Medical Oncology at Sidney Kimmel Cancer Center at Jefferson. She received her medical degree from Icahn School of Medicine at Mount Sinai. She completed her residency at Mount Sinai School of Medicine and her fellowship at New York Presbyterian Hospital. Dr. Jaslow specializes in treating patients with breast and ovarian cancers and provides management expertise for patients at high-risk for breast and ovarian cancers.
Daniel Silver, MD, PhD
Daniel Silver, MD, PhD, is an Associate Professor in the departments of Medical Oncology and Cancer Biology at the Sidney Kimmel Cancer Center at Jefferson. He is also the director of Basic Science and Research in Medical Oncology as well as the leader of the Breast Cancer Program at SKCC. He received his medical degree from the University of California, San Francisco. He completed his residency at the University of California, San Francisco and his fellowship in Medical Oncology at the Dana Farber Cancer Institute. Dr. Silver specializes in treating patients with breast cancer and those at high risk of breast cancer; he contributes his expertise in breast cancer treatment and high-risk management to the Clinical Cancer Genetics Program.